Department of Pharmaceutical Sciences, College of Pharmacy, University of Arizona, Tucson, Arizona 85721, USA.
J Pharm Sci. 2012 Sep;101(9):3047-50. doi: 10.1002/jps.23093. Epub 2012 Feb 28.
Methods such as pH adjustment, cosolvency, complexation, and micellization are routinely used to increase the concentration of dissolved drug in the gastrointestinal (GI) lumen over that of a saturated solution. However, these solubilizing agents also reduce the membrane-water distribution coefficient so that the membrane transport rate is not changed. Also, dilution of a formulation upon administration results in: (1) a pH change toward that of the GI fluid, (2) an exponential decrease in cosolvency, and (3) disassociation of complexes and the disintegration of micelles. As a result, these solubilizing agents cannot be expected to produce any increase in membrane transport-limited drug absorption over that of a suspension of unformulated drug.
方法如 pH 值调节、共溶剂、络合作用和胶束化等,通常用于增加胃肠道(GI)腔内溶解药物的浓度,超过饱和溶液的浓度。然而,这些增溶剂也会降低膜-水分配系数,从而使膜转运速率不变。此外,制剂给药后的稀释会导致:(1)pH 值向胃肠道液体的方向变化,(2)共溶剂呈指数下降,以及(3)络合物的解离和胶束的崩解。因此,这些增溶剂不能期望比未成型药物的混悬液在膜转运受限药物吸收方面产生任何增加。